A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study assesses the maximum tolerated dose, overall safety and antitumor activity of
SU011248 in combination with capecitabine in patients with advanced solid tumors